[1] |
Wang JM, Lin SR. Research and new treatment progress of gastric cancer[J].Wei Chang Bing Xue He Gan Bing Xue Za Zhi, 2012, 21 (1): 3-5. [王婕敏, 林三仁. 胃癌研究及诊治新进展[J]. 胃肠病 学和肝病学杂志, 2012, 21(1): 3-5.]
|
[2] |
Fu XJ, Chen RC. Clinical significance of seasonal changes of 25 -(OH) D in inflammatory bowel disease patients [J]. Fang She Mian Yi Xue Za Zhi, 2013, 26(3): 362-4.[傅晓娟, 陈如昌. 炎症 性肠病患者25-羟基维生素D季节变化的临床意义[J]. 放射免 疫学杂志, 2013, 26(3): 362-4.]
|
[3] |
Yamana K, Saito H, Takenouchi K, et al. Vitamin D and cancer[J]. Clini Calcium, 2006, 16(7): 1147-53.
|
[4] |
Xue M, Fang Y, Sun G, et al. IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer [J] PLoS One, 2013, 8(12): e81423.
|
[5] |
Miao YE, Wang J, Wang WB. Expression of vitamin D receptor in gastric carcinoma and normal mucosa adjacent to carcinoma[J]. Shandong Da Xue Xue Bao(Yi Xue Ban), 2012, 50(2): 74-7. [缪 玉娥, 王珏, 王潍博. 胃癌及其癌旁黏膜中维生素D受体的表达 [J] 山东大学学报(医学版), 2012, 50(2): 74-7.]
|
[6] |
Shi X, Li X, Chen L, et al. Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer[J]. Oncol Lett, 2013, 6(6): 1794-8.
|
[7] |
Zhuang ZG, Yu JM, Jiang BQ, et al. Measurement and clinical significance of serum 25-(OH)D in breast cancer patients[J]. Shi Yong Yi Xue Za Zhi, 2010, 26(2):244-6. [庄志刚, 余剑敏, 蒋蓓 琦, 等. 乳腺癌患者外周血25羟基维生素D测定及临床意义[J]. 实用医学杂志, 2010, 26(2): 244-6.]
|
[8] |
Finkelmeier F, Kronenberger B, Köberle V, et al. Severe 25 -hydroxyvitamin D deficiency identifies a poor prognosis in patients hepatocellular carcinoma a prospective cohort study[J]. Aliment Pharmacol Ther, 2014, 39(10): 1204-12.
|
[9] |
Kilkkinen A, Knekt P, Heliövaara M, et al. Vitamin D status and the risk of lung Cancer: a cohort study in Finland[J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(11): 3274-8.
|
[10] |
Hong SN, Kim JH, Choe WH, et al. Circulating vitamin D and colorectal adenoma in asymptomatic average-risk individuals who underwent first screening colonoscopy: a case-control study[J]. Dig Dis Sci, 2012, 57(3): 753-63.
|
[11] |
Wulaninqsih W, Michaelsson K, Garmo H, et al. Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study[J]. BMC Public Heath, 2013, 13(1): 663.
|
[12] |
Galas A, Augustyniak M, Sochacka-Tatara E. Does dietary calcium interact fiber against colorectal cancer? A case-control study in Central Europe[J]. Nutr J, 2013, 12: 134.
|
[13] |
Kim KZ,Shin A, Kim J, et al. Association between CASR polymorphisms, calcium intake, and colorectal cancer risk[J]. PLoS One, 2013, 8(3): e59628.
|
[14] |
Xie BJ, Zheng CM, Peng JR. Clinical significance of peripheral 25 -(OH)D measuring in gastrointestinal cancer patients[J]. Hebei Yi Yao, 2011, 33(24): 3711-2. [谢宝江, 郑晟旻, 彭吉润. 消化道 恶性肿瘤患者外周血25-羟基维生素D测定的临床意义[J]. 河 北医药, 2011, 33(24): 3711-2.]
|